PMID: 11320855Apr 26, 2001Paper

The return of thalidomide

Recenti progressi in medicina
G Rossi

Abstract

Nearly four decades after its withdrawal from the marketplace because of the discover of its teratogenicity, the thalidomide is now attracting a renewed interest due to the identification of its important anti-inflammatory, immunomodulatory and anti-angiogenic effects. After the approval in the United States of the thalidomide for treatment of erythema nodosum leprosum, several studies have been conducted in patients with dermatologic disorders, conditions associated with HIV infection, graft-versus-host disease, rheumatoid arthritis, Cron's disease, and cancer. In this paper the mechanisms of action of thalidomide and its indications in human diseases are summarized.

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Related Papers

Current Oncology Reports
Robert J Amato
The American Journal of Medicine
L Calabrese, A B Fleischer
Journal of the American Academy of Dermatology
Virginia C HallS Vincent Rajkumar
Expert Opinion on Investigational Drugs
L Calabrese, Ken E Resztak
Expert Opinion on Drug Metabolism & Toxicology
Iris Breitkreutz, Kenneth Anderson
© 2021 Meta ULC. All rights reserved